Gilead Sciences Inc (GILD)

Operating return on assets (Operating ROA)

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Operating income (ttm)	US$ in thousands	8,329,000	8,384,000	10,119,000	9,096,000	8,499,000	8,260,000	8,474,000	8,838,000	6,694,000	5,367,000	6,372,000	6,589,000	9,918,000	11,629,000	9,788,000	4,559,000	4,071,000	2,513,000	-961,000	4,452,000
Total assets	US$ in thousands	58,995,000	54,525,000	53,579,000	56,292,000	62,125,000	62,373,000	62,337,000	61,876,000	63,171,000	62,557,000	62,870,000	63,080,000	67,952,000	67,098,000	67,984,000	67,492,000	68,407,000	60,878,000	55,934,000	59,741,000
Operating ROA		14.12%	15.38%	18.89%	16.16%	13.68%	13.24%	13.59%	14.28%	10.60%	8.58%	10.14%	10.45%	14.60%	17.33%	14.40%	6.75%	5.95%	4.13%	-1.72%	7.45%

December 31, 2024 calculation

Operating ROA = Operating income (ttm) ÷ Total assets
= $8,329,000K ÷ $58,995,000K
= 14.12%

Gilead Sciences Inc's operating return on assets (operating ROA) has shown fluctuations over the provided periods. The operating ROA ranged from -1.72% to 18.89% during the timeframe, with a general upward trend observed from June 30, 2020, to June 30, 2024.

The highest operating ROA was recorded on June 30, 2024, at 18.89%, indicating that Gilead Sciences was efficient in generating operating income relative to its total assets at that point in time. Conversely, the lowest operating ROA was -1.72% on June 30, 2020, suggesting that the company experienced challenges in utilizing its assets to generate operating profits.

Overall, the trend in Gilead Sciences Inc's operating ROA demonstrates positive performance with variability over the periods. Analyzing the reasons behind these fluctuations could provide insights into the company's operational efficiency and financial management strategies.